PARP1 and atherosclerosis: PARP-1 inhibition may also have a major impact on endothelial function, foam cell formation, lipid metabolism and the induction of cell death (switch from necrosis to apoptosis), all of which are central to the pathogenesis of atherosclerosis (Xu et al., 2014).